Furthermore, dysfunctional AMPK could have a key role in advanced NAFLD since it was recently shown that the kinase can phosphorylate the proapoptotic caspase 6 to inhibit its activation and to control for hepatocellular apoptosis in NASH [212]. Here, PRKAA1 is linked to metabolic dysfunction-associated steatohepatitis.